Online inquiry

IVTScrip™ mRNA-Anti-TLR3 Agonist, HspE7(Cap 1, Pseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ8447MR)

This product GTTS-WQ8447MR is a type of mRNA modified with Pseudo-UTP, which ecodes the monoclonal antibody that targets TLR3 Agonist. The antibody can be applied in Cervical dysplasia vaccine research.

Specifications
Product type	mRNA
Modified bases	Pseudo-UTP
5' Cap	Cap 1
Species	Mycobacterium tuberculosis variant bovis; Alphapapillomavirus 9
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-TLR3 Agonist, HspE7(Cap 1, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WQ8447MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ4484MR	IVTScrip™ mRNA-Anti-CD28, BMS-931699(Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	BMS-931699
GTTS-WQ8977MR	IVTScrip™ mRNA-Anti-IL22, ILV-094(Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	ILV-094
GTTS-WQ15051MR	IVTScrip™ mRNA-Anti-CD47, SRF-231(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	SRF-231
GTTS-WQ1637MR	IVTScrip™ mRNA-Anti-F10&F9, ACE-910(Cap 1, Pseudo-UTP, 30 nt-poly(A))	mRNA	ACE-910
GTTS-WQ3574MR	IVTScrip™ mRNA-Anti-LYPD3, BAY 1112623(Cap 1, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	BAY 1112623
GTTS-WQ13369MR	IVTScrip™ mRNA-Anti-LRRC15, PR-1498487(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	PR-1498487
GTTS-WQ6550MR	IVTScrip™ mRNA-Anti-TNF, D2E7(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	D2E7
GTTS-WQ9891MR	IVTScrip™ mRNA-Anti-pcrV, KB001-A(Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))	mRNA	KB001-A

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST